Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of GST-tagged human CDK2/Cyclin A2 expressed in baculovirus infected Sf9 cells using 5-FAM-QSPKKG-CONH2 as substrate incubated for 60 mins in presence of ATP
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to recombinant STK4 (unknown origin) assessed as dissociation constant by DSF assay
Binding affinity to recombinant MARK4 (unknown origin) assessed as dissociation constant by DSF assay
Binding affinity to recombinant MARK3 (unknown origin) assessed as dissociation constant by DSF assay
Binding affinity to recombinant BMP2K (unknown origin) assessed as dissociation constant by DSF assay
Inhibition of PKA (unknown origin)
Cytotoxicity against human HeLa S3 cells measured after 72 hrs
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Biochemical Assay from US Patent US20240002365: "PYRIDAZINE AND 1,2,4-TRIAZINE DERIVATIVES AS FGFR KINASE INHIBITORS"
Assay data:3 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Assay data:6 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 7 Tested
Inhibition of recombinant His-tagged human FLT3 D835Y mutant (564 to 958 residues) expressed in baculovirus expression system by LanthaScreen assay
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of recombinant N-terminal GST/His6-tagged human FLT3 ITD mutant (571 to 993 residues) expressed in insect cells by LanthaScreen assay
Inhibition of Aurora A (unknown origin) using kemptide as substrate incubated for 50 mins in the presence of ATP by ADP-Glo reagent based luminescence assay
Assay data:2 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 2 Tested
Inhibition of SYK (unknown origin)
Inhibition of Lyn (unknown origin)
Inhibition of FLT3 (unknown origin)
Inhibition of Aurora A(unknown origin)
Inhibition of ALK (unknown origin)
Biochemical Inhibition Assay from US Patent US9206188: "Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors"
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
in vitro Kinase Assay from Article 10.1021/cb9002865: "In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors."
Assay data:7 Active, 1 Activity ≤ 1 nM, 7 Activity ≤ 1 µM, 7 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
CDK Activity Assay. from Article 10.1074/jbc.M201233200: "Structural basis for Chk1 inhibition by UCN-01."
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on